Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | AMGN | BMY | VRTX | GILD |
| Company | Reata Pharma | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 172.34 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 172.46 | 290.57 | 58.48 | 455.43 | 89.94 |
| Low | 172.32 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 172.36 | 290.52 | 58.34 | 450.03 | 89.58 |
| Change | +0.04 | +2.65 | +0.46 | -1.20 | +0.95 |
| % Change | +0.02% | +0.92% | +0.79% | -0.27% | +1.07% |
| Volume | 1,988,500 | 1,691,153 | 4,246,053 | 806,436 | 2,041,564 |
| 20-Day Average Volume | 810,510 | 2,827,044 | 12,232,043 | 1,308,807 | 7,424,813 |
| Previous Close | 172.32 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 307.44 | 55.93 | 479.24 | 90.88 |
| 20-Day Raw Stochastic | 97.36% | 28.18% | 71.30% | 6.98% | 27.93% |
| 20-Day Relative Strength | 81.56% | 36.90% | 61.12% | 40.88% | 53.37% |
| Weighted Alpha | +177.60 | +2.17 | +26.61 | +18.05 | +25.87 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 100% Buy | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | -1.87% since 11/14/24 | -0.14% since 11/14/24 | -6.95% since 11/14/24 | -2.66% since 11/14/24 |
| Low | 171.96 on 09/19/23 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 172.46 on 09/25/23 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | -8.31% since 10/21/24 | +12.09% since 10/21/24 | -5.80% since 10/21/24 | +3.91% since 10/21/24 |
| Low | 168.67 on 09/05/23 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 172.46 on 09/25/23 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | -11.77% since 08/21/24 | +20.60% since 08/21/24 | -7.36% since 08/21/24 | +19.34% since 08/21/24 |
| Low | 88.80 on 06/27/23 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 172.46 on 09/25/23 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | -7.76% since 05/21/24 | +38.21% since 05/21/24 | +1.89% since 05/21/24 | +33.24% since 05/21/24 |
| Low | 76.54 on 05/10/23 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 172.46 on 09/25/23 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 38,150 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 2,220,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -311,900,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 22,750,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | 193,000,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.42 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/14/23 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |